CBAY.US | summary | financial summary | prediction chart | global stock news | news graph | volatility | components |pairs | earnings | dividends | sales | compare

symbol		last	change	%chng	name	mcap	sector	wiki
CBAY	US				Cymabay Therapeu

Market global news for CBAY (US) Cymabay Therapeu

Global news - US chevrons indicate local prediction, arrows show global predictions

Today

previous days

	Jennison Associates LLC Increases Holdings in CymaBay Therapeutics, Inc. (NASDAQ:CBAY) tickerreport - 13:30 Tue 23 - CBAY - link story
	Today's Biggest Losers \| MENAFN.COM menafn - 13:00 Fri 19 - CBAY - link story
	CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Receives Average Recommendation of "Hold" from Analysts theenterpriseleader - 09:45 Thu 18 - CBAY - link story
	Xeno Biosciences Announces New CEO and Financing streetinsider - 17:45 Wed 17 - CBAY - link story
	CymaBay Therapeutics (NASDAQ:CBAY) & Revance Therapeutics (NASDAQ:RVNC) Head-To-Head Survey themarketsdaily - 16:45 Wed 17 - CBAY - link story
	Head to Head Contrast: CymaBay Therapeutics (NASDAQ:CBAY) vs. Revance Therapeutics (NASDAQ:RVNC) theenterpriseleader - 16:45 Wed 17 - CBAY - link story
	CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Given Average Rating of "Hold" by Brokerages tickerreport - 08:15 Tue 16 - CBAY - link story
	CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Receives Average Recommendation of "Hold" from Brokerages wkrb13 - 08:00 Tue 16 - CBAY - link story
	CymaBay Therapeutics (NASDAQ:CBAY) Research Coverage Started at StockNews.com wkrb13 - 09:00 Sun 14 - CBAY - link story
	Seladelpar normalizes ALP, reduces pruritis vs. placebo in primary biliary cholangitis healio - 18:15 Wed 10 - CBAY - link story
	CymaBay Therapeutics (NASDAQ:CBAY) Earns Sell Rating from Analysts at StockNews.com tickerreport - 07:00 Sun 7 - CBAY - link story
	Opthea Appoints Sujal Shah To Its Board Of Directors miragenews - 04:45 Thu 4 - CBAY - link story
	Opthea Appoints Sujal Shah to the Board of Directors wallstreet-online de - 22:45 Wed 3 - CBAY - link story
	Opthea Appoints Sujal Shah to the Board of Directors tmcnet - 22:30 Wed 3 - CBAY - link story
	Opthea (OPT) Appoints Sujal Shah to its Board streetinsider - 22:00 Wed 3 - CBAY - link story
	Opthea Appoints Sujal Shah to the Board of Directors globenewswire - 22:00 Wed 3 - CBAY - link story
	Opthea Appoints Sujal Shah to the Board of Directors yahoo - 22:00 Wed 3 - CBAY - link story
	Fierce Biotech's Quarterly IPO and M&A Roundup: Q1'24 fiercebiotech - 15:30 Wed 3 - CBAY - link story
	CymaBay Therapeutics (NASDAQ:CBAY) Now Covered by Analysts at StockNews.com themarketsdaily - 06:45 Fri 29 - CBAY - link story
	Assenagon Asset Management S.A. Invests $17.63 Million in CymaBay Therapeutics, Inc. (NASDAQ:CBAY) etfdailynews - 10:30 Thu 28 - CBAY - link story
	Tvardi Therapeutics Appoints Sujal Shah as Chairman and Adds Shaheen Wirk to the Board of Directors streetinsider - 13:45 Tue 26 - CBAY - link story
	Gilead Sciences Completes Acquisition of CymaBay finsmes - 14:45 Mon 25 - CBAY - link story
	CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Shares Bought by Legato Capital Management LLC theenterpriseleader - 18:15 Sun 24 - CBAY - link story
	Gilead Sciences Completes Acquisition Of CymaBay Therapeutics finanznachrichten de - 14:45 Fri 22 - CBAY - link story
	Gilead Sciences Announces Completion of Acquisition of CymaBay wallstreet-online de - 14:30 Fri 22 - CBAY - link story
	Gilead (GILD) reduces 2024 earnings guidance after completing CymaBay takeover streetinsider - 14:15 Fri 22 - CBAY - link story
	Gilead Sciences (GILD) Announces Completion of Acquisition of CymaBay (CBAY) streetinsider - 13:45 Fri 22 - CBAY - link story
	Form SC 14D9/A CymaBay Therapeutics, Filed by: CymaBay Therapeutics, Inc. streetinsider - 12:15 Fri 22 - CBAY - link story
	CymaBay Therapeutics (NASDAQ:CBAY) Reaches New 52-Week High at $32.48 tickerreport - 15:15 Mon 18 - CBAY - link story
	CymaBay Therapeutics (NASDAQ:CBAY) Hits New 1-Year High at $32.48 wkrb13 - 15:15 Mon 18 - CBAY - link story